Autophagy-Mediated Insulin Receptor Down-Regulation Contributes to Endoplasmic Reticulum Stress-Induced Insulin Resistance
Endoplasmic reticulum (ER) stress is associated with obesity-induced insulin resistance, yet the underlying mechanisms remain to be fully elucidated. Here we show that ER stress-induced insulin receptor (IR) down-regulation may play a critical role in obesity-induced insulin resistance. The expressi...
Gespeichert in:
Veröffentlicht in: | Molecular pharmacology 2009-09, Vol.76 (3), p.596-603 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Endoplasmic reticulum (ER) stress is associated with obesity-induced insulin resistance, yet the underlying mechanisms remain
to be fully elucidated. Here we show that ER stress-induced insulin receptor (IR) down-regulation may play a critical role
in obesity-induced insulin resistance. The expression levels of IR are negatively associated with the ER stress marker C/EBP
homologous protein (CHOP) in insulin target tissues of db / db mice and mice fed a high-fat diet. Significant IR down-regulation was also observed in fat tissue of obese human subjects
and in 3T3-L1 adipocytes treated with ER stress inducers. ER stress had little effect on IR tyrosine phosphorylation per se
but greatly reduced IR downstream signaling. The ER stress-induced reduction in IR cellular levels was greatly alleviated
by the autophagy inhibitor 3-methyladenine but not by the proteasome inhibitor N -benzoyloxycarbonyl ( Z )-Leu-Leu-leucinal (MG132). Inhibition of autophagy prevented IR degradation but did not rescue IR downstream signaling, consistent
with an adaptive role of autophagy in response to ER stress-induced insulin resistance. Finally, chemical chaperone treatment
protects cells from ER stress-induced IR degradation in vitro and obesity-induced down-regulation of IR and insulin action
in vivo. Our results uncover a new mechanism underlying obesity-induced insulin resistance and shed light on potential targets
for the prevention and treatment of obesity-induced insulin resistance and type 2 diabetes. |
---|---|
ISSN: | 0026-895X 1521-0111 |
DOI: | 10.1124/mol.109.057067 |